By 2030, will gene editing to cure serious genetic diseases be seen as generally uncontroversial?
Health & MedicineOne-Off4J
Manifold MarketsKein KYCVerifizierte AuflösungsdatenOrdentlich kalibriertAktuelle Community-Prognose
Nein 79.3%
Prognostiker
47
Fragetyp
binary
Methodik
Play-money forecasting platform
Quellentyp
Prognose
Marktdaten
Aktualisiert vor 5 Stunden
Veraltet23. Dez. 22, 02:32 UTC31. Dez. 30, 23:59 UTC
Trends
Verwandte Märkte
Verwandte Fragen als Kontext, kein Vergleich gleichwertiger Kontrakte.
[ACX 2026] Will the US, UK or EU approve a gene editing therapy for a new condition during 2026?
Manifold MarketsWill the US, UK or EU approve a gene editing therapy for a new condition during 2026?
FutuurPrompt caching is seen as the wrong path for context management, in December 2026? [0.005 Seconds prediction]
Manifold MarketsWill mother-son incest be widely seen as more socially acceptable than eating chicken by 2040?
Manifold MarketsBumetanide considered effective in the treatment of genetic Alzheimer's by the end of 2026?
FutuurWill CDC cut the childhood vaccine schedule below 11 diseases in 2026?
KalshiRegeln
Many people do not currently see gene editing to cure e.g., cancer, sickle-cell, or down syndrom as a clear moral good that humanity should be persuing.
- Will this change by 2030?
- Currently, I count ~40% of the most recent tweets containing the term "gene editing" as clearly negative; "gene therapy" is much, much worse.
- Twitter may not be the most approprite source by time of resolution, but I will try to find a broadly equivalnt source of popular opinion.
- When I look at statements of popular opinion, will at least 90% be positive or neutral? By default, I will treat technical statements of valid research as neutral, even if they show negative results or document risks.
- I will search for whatever term or terms are most commonly used in 2030.
Offene Märkte
Health & Medicine
POLYMARKETHantavirus pandemic in 2026?
- No-0.1pt97%
- Yes+0.1pt3%
- Gesamtvolumen
- 15,6 Mio. €
- 24h-Volumen
- 18.288,2 €
KALSHIWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
- No96%
- Yes+1.9pt4%
- Gesamtvolumen
- 1,6 Mio. €
- 24h-Volumen
- 5178,9 €
KALSHIWhen will Intellia Therapeutics submit a BLA for Lonvo-z?
- before October+64.0pt98%
- before 2027+22.0pt98%
- before December+30.0pt98%
+3 weitere Ergebnisse
POLYMARKETFDA approves skin cancer vaccine by which date?
- December 31,+6.0pt65%
- September+2.0pt41%
- June28%
- Gesamtvolumen
POLYMARKETNew pandemic in 2026?
- No+0.5pt94%
- Yes-0.5pt6%
- Gesamtvolumen
- 916.002,6 €
- 24h-Volumen
- 1515,1 €
KALSHIMeasles cases in 2026?
- Above 300099%
- Above 400097%
- Above 6000-2.0pt57%
+2 weitere Ergebnisse
- Gesamtvolumen
- 863.640,2 €
- 24h-Volumen
- 1039 €
- Ebola pandemic in 2026?
- Will 3 mg THC beverages be federally legal to sell?
- Ebola pandemic in 2026?
- Measles cases in U.S. in 2026?
- FDA decision: Bepirovirsen by GlaxoSmithKline (in 2026)
- When will Heidi Overton be confirmed as Commissioner of the FDA?
- What will the average number of measles cases be during Trump's term?
- Will the FDA approve any psychedelic substance for medical use this year?
- When will the FDA reclassify BPC-157 to Category 1?
- FDA decision: Saroglitazar by Zydus Therapeutics (in 2026)
- Will the FDA approve CagriSema?
- When will Compass Pathways submit a NDA for COMP360 psilocybin?
Häufige Fragen
- Wie stehen die aktuellen Quoten für By 2030, will gene editing to cure serious genetic diseases be seen as generally uncontroversial??
- Manifold Markets bewertet No mit 79% (Stand: 8. September 2026).
- Wann wird By 2030, will gene editing to cure serious genetic diseases be seen as generally uncontroversial? entschieden?
- By 2030, will gene editing to cure serious genetic diseases be seen as generally uncontroversial? soll am 31. Dezember 2030 entschieden werden.
- Wie wird By 2030, will gene editing to cure serious genetic diseases be seen as generally uncontroversial? abgerechnet?
- Manifold Markets rechnet diesen Markt wie folgt ab: Many people do not currently see gene editing to cure e.g., cancer, sickle-cell, or down syndrom as a clear moral good that humanity should be persuing.